SBC Medical Q4 Revenue Drops 11%, Net Income Soars 117%

By Chris Stiles • Friday, March 27 07:54 • Permanent Link

SBC Medical Group Holdings reported fourth-quarter 2025 revenue of $40 million, down 11% from a year earlier, even as profitability improved sharply.

Net income attributable to the company rose to $14 million, up 117% year over year. Earnings per share more than doubled to $0.14 from the prior-year quarter, a 133% increase.

The company said EBITDA fell 35% to $14 million, while EBITDA margin declined to 34% from the prior-year level, a drop of 12 percentage points.

Return on equity increased to 23%, up 9.8 percentage points from a year earlier.

Operationally, SBC Medical ended the quarter with 283 franchise locations, up 34 from December 31, 2024. Customer volume over the trailing 12 months reached 6.6 million, a 12% increase year over year. The company also said its repeat rate for customers who visited franchise clinics twice or more was 72%.

For the full year, the release did not provide additional headline figures beyond the fourth-quarter metrics included above. As a result of these announcements, the company's shares have moved -3.77% on the market, and are now trading at a price of $4.34. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.